The Lens Opacities Classification System III grading in irradiated uveal melanomas to characterize proton induced cataracts

Ocular Oncology

Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D

Ophthalmology.

Vichitvejpaisal P, Dalvin LA, Mazloumi M, Ewens KG, Ganguly A, Shields CL

doi: 10.1016/j.ophtha.2019.04.027.

Ocular Oncology

Corneal Substructure Dosimetry Predicts Corneal Toxicity in Patients with Uveal Melanoma Treated with Proton Beam Therapy

Int J Radiat Oncol Biol Phys.

Lee HJ Jr, Stacey A, Klesert TR, Wells C, Skalet A, Bloch C, Fung A, Bowen SR, Wong TP, Shibata D, Halasz LM, Rengan R

doi: 10.1016/j.ijrobp.2019.02.005.

Ocular Oncology

Effects of plaque brachytherapy and proton beam radiotherapy on prognostic testing: a comparison of uveal melanoma genotyped by microsatellite analysis

Br J Ophthalmol.

Thornton S, Coupland SE, Heimann H, Hussain R, Groenewald C, Kacperek A, Damato B, Taktak A, Eleuteri A, Kalirai H

doi: 10.1136/bjophthalmol-2019-315363.

UveitisFurther Publications

Adding TCGA chromosome classes to AJCC system allows for more precise prognostication in uveal melanoma patients

Ophthalmology

Gelmi MC, Bas Z, Malkani K, Ganguly A, Shields CL, Jager MJ

doi: 10.1016/j.ophtha.2021.11.018

LensesCataracts

The Influence of Cataract on Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO)

Transl Vis Sci Technol

Lincke JB, Dysli C, Jaggi D, Fink R, Wolf S, Zinkernagel MS

doi: 10.1167/tvst.10.4.33

Ocular Oncology

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition

Eur J Cancer.

Heppt MV, Heinzerling L, Kähler KC, Forschner A, Kirchberger MC, Loquai C, Meissner M, Meier F, Terheyden P, Schell B, Herbst R, Göppner D, Kiecker F, Rafei-Shamsabadi D, Haferkamp S, Huber MA, Utikal J, Ziemer M, Bumeder I, Pfeiffer C, Schäd SG, Schmid-Tannwald C, Tietze JK, Eigentler TK, Berking C

doi: 10.1016/j.ejca.2017.05.038.

Macular Diseases

VALIDATION OF THE RECENTLY DEVELOPED ATN CLASSIFICATION AND GRADING SYSTEM FOR MYOPIC MACULOPATHY

Retina.

Ruiz-Medrano J, Flores-Moreno I, Ohno-Matsui K, Cheung CMG, Silva R, Ruiz-Moreno JM

doi: 10.1097/IAE.0000000000002725.

Glaucoma and Ocular PressureOcular Oncology

Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects

Graefes Arch Clin Exp Ophthalmol.

Riechardt AI, Klein JP, Cordini D, Heufelder J, Rehak M, Seibel I, Joussen AM

doi: 10.1007/s00417-018-3929-5.

Glaucoma and Ocular PressureOcular Oncology

New classification system for pediatric glaucoma: implications for clinical care and a research registry

Curr Opin Ophthalmol.

Thau A, Lloyd M, Freedman S, Beck A, Grajewski A, Levin AV

doi: 10.1097/ICU.

Related content

Genetic Analysis of Uveal Melanoma in 658 Patients Using the Cancer Genome Atlas Classification of Uveal Melanoma as A, B, C, and D

Corneal Substructure Dosimetry Predicts Corneal Toxicity in Patients with Uveal Melanoma Treated with Proton Beam Therapy

Effects of plaque brachytherapy and proton beam radiotherapy on prognostic testing: a comparison of uveal melanoma genotyped by microsatellite analysis

Adding TCGA chromosome classes to AJCC system allows for more precise prognostication in uveal melanoma patients

The Influence of Cataract on Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO)

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition

VALIDATION OF THE RECENTLY DEVELOPED ATN CLASSIFICATION AND GRADING SYSTEM FOR MYOPIC MACULOPATHY

Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects

New classification system for pediatric glaucoma: implications for clinical care and a research registry